Avic Chengdu Aircraft
302132
Wuhan Honghai Technology
920108
Yalian Machinery
001395
4
Beijing HyperStrong Technology
688411
5
Fuling Technology
001356
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.